Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Luther

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
American Heart Journal|October 1, 1991
Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilatJ M Neutel, R R Luther, R S Boger, et al.
The American Journal of Medicine|May 23, 1986
Efficacy of terazosin as an antihypertensive agentR R Luther, H N Glassman, D C Jordan, et al.
Arzneimittel-Forschung|January 1, 1989
Renin inhibitors: specific modulators of the renin-angiotensin systemR R Luther, H H Stein, H N Glassman, et al.
Journal of Neurotrauma|November 5, 1999
Effects of an N-type calcium channel antagonist (SNX 111; Ziconotide) on calcium-45 accumulation following fluid-percussion injuryA Samii, H Badie, K Fu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1997
Pharmacokinetics of SNX-111, a selective N-type calcium channel blocker, in rats and cynomolgus monkeysS Bowersox, J Mandema, K Tarczy-Hornoch, et al.
The American Journal of Medicine|May 23, 1986
Overall safety of terazosin as an antihypertensive agentW D Sperzel, H N Glassman, D C Jordan, et al.
The Journal of International Medical Research|January 1, 1986
Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agentR R Luther, H N Glassman, D C Jordan, et al.
American Heart Journal|September 1, 1991
Antihypertensive dose-response relationships: studies with the selective alpha 1-blocking agent terazosinM A Weber, D G Cheung, A R Laddu, et al.
The Clinical Journal of Pain|September 26, 1997
Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion painW G Brose, D P Gutlove, R R Luther, et al.
Journal of Clinical Pharmacology|September 1, 1988
Pharmacologic effects of A-56234, a new high-ceiling diureticR R Luther, G L Ringham, E W Thomas, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
American Heart Journal|October 1, 1991
Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilatJ M Neutel, R R Luther, R S Boger, et al.
The American Journal of Medicine|May 23, 1986
Efficacy of terazosin as an antihypertensive agentR R Luther, H N Glassman, D C Jordan, et al.
Arzneimittel-Forschung|January 1, 1989
Renin inhibitors: specific modulators of the renin-angiotensin systemR R Luther, H H Stein, H N Glassman, et al.
Journal of Neurotrauma|November 5, 1999
Effects of an N-type calcium channel antagonist (SNX 111; Ziconotide) on calcium-45 accumulation following fluid-percussion injuryA Samii, H Badie, K Fu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1997
Pharmacokinetics of SNX-111, a selective N-type calcium channel blocker, in rats and cynomolgus monkeysS Bowersox, J Mandema, K Tarczy-Hornoch, et al.
The American Journal of Medicine|May 23, 1986
Overall safety of terazosin as an antihypertensive agentW D Sperzel, H N Glassman, D C Jordan, et al.
The Journal of International Medical Research|January 1, 1986
Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agentR R Luther, H N Glassman, D C Jordan, et al.
American Heart Journal|September 1, 1991
Antihypertensive dose-response relationships: studies with the selective alpha 1-blocking agent terazosinM A Weber, D G Cheung, A R Laddu, et al.
The Clinical Journal of Pain|September 26, 1997
Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion painW G Brose, D P Gutlove, R R Luther, et al.
Journal of Clinical Pharmacology|September 1, 1988
Pharmacologic effects of A-56234, a new high-ceiling diureticR R Luther, G L Ringham, E W Thomas, et al.
Pageof 5